Effect of Tenofovir on Nucleotidases and Cytokines in HIV-1 Target Cells

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Biswas, Nabanita ^a   Rodriguez Garcia, Marta ^a   Crist, Sarah G ^a   Shen, Zheng ^a   Bodwell, Jack E ^a   Fahey, John V ^a   Wira, Charles R ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5' ECTONUCLEOTIDASE; CYTOKINE; CYTOSOLIC 5' (3') DEOXYRIBONUCLEOTIDASE; CYTOSOLIC 5' NUCLEOTIDASE 1A; CYTOSOLIC 5' NUCLEOTIDASE 1B; CYTOSOLIC 5' NUCLEOTIDASE II; CYTOSOLIC 5' NUCLEOTIDASE III; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MESSENGER RNA; MITOCHONDRIAL 5'(3') DEOXYRIBONUCLEOTIDASE; NUCLEOTIDASE; RNA; TENOFOVIR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CD4+ T LYMPHOCYTE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; ENZYME ACTIVITY; ENZYME INHIBITION; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IL 8 GENE; IMMUNOCOMPETENT CELL; INNATE IMMUNITY; MACROPHAGE; MIP3ALPHA GENE; MONOCYTE DERIVED MACROPHAGE; MUCOSA INFLAMMATION; NORMAL HUMAN; NT5C1B GENE; NT5E GENE; NT5M GENE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE ACTIVATION; TNFALPHA GENE;

5'-NUCLEOTIDASE; ADENINE; CD4-POSITIVE T-LYMPHOCYTES; CYTOKINES; DENDRITIC CELLS; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HIV-1; HUMANS; IMMUNITY, INNATE; IMMUNOLOGIC FACTORS; LYMPHOCYTE ACTIVATION; MACROPHAGES; ORGANOPHOSPHONATES; TIME FACTORS;

EID: 84886413690     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0078814     Document Type: Article

References (45)

1. UNAIDS (2012) UNAIDS report on the global AIDS epidemic.
2. De Clercq E, (2007) Acyclic nucleoside phosphonates: past, present and future. Bridging chemistry to HIV, HBV, HCV, HPV, adeno-, herpes-, and poxvirus infections: the phosphonate bridge. Biochem Pharmacol 73: 911-922.
3. van der Straten A, Van Damme L, Haberer JE, Bangsberg DR, (2012) Unraveling the divergent results of pre-exposure prophylaxis trials for HIV prevention. AIDS 26: F13-F19. doi:10.1097/QAD.0b013e3283522272. PubMed: 22333749.
4. Abdool Karim Q, Abdool Karim SS, Frohlich JA, Grobler AC, Baxter C, et al. (2010) Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science 329: 1168-1174. doi:10.1126/science.1193748. PubMed: 20643915.
5. (2012) MTN. Microbicide Trials; Network Statement on Decision to Discontinue Use of Tenofovir Gel in VOICE, a Major HIV Prevention Study in Women.
6. Balzarini J, Hao Z, Herdewijn P, Johns DG, De Clercq E, (1991) Intracellular metabolism and mechanism of anti-retrovirus action of 9-(2-phosphonylmethoxyethyl)adenine, a potent anti-human immunodeficiency virus compound. Proc Natl Acad Sci U S A 88: 1499-1503. doi:10.1073/pnas.88.4.1499. PubMed: 1705039.
7. Balzarini J, Holy A, Jindrich J, Dvorakova H, Hao Z, et al. (1991) 9-[(2RS)-3-fluoro-2-phosphonylmethoxypropyl] derivatives of purines: a class of highly selective antiretroviral agents in vitro and in vivo. Proc Natl Acad Sci U S A 88: 4961-4965. doi:10.1073/pnas.88.11.4961. PubMed: 1711214.
8. Gallant JE, Staszewski S, Pozniak AL, DeJesus E, Suleiman JM, et al. (2004) Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial. JAMA 292: 191-201. doi:10.1001/jama.292.2.191. PubMed: 15249568.
9. Robbins BL, Greenhaw J, Connelly MC, Fridland A, (1995) Metabolic pathways for activation of the antiviral agent 9-(2-phosphonylmethoxyethyl)adenine in human lymphoid cells. Antimicrob Agents Chemother 39: 2304-2308. doi:10.1128/AAC.39.10.2304. PubMed: 8619586.
10. Anderson PL, Kiser JJ, Gardner EM, Rower JE, Meditz A, et al. (2011) Pharmacological considerations for tenofovir and emtricitabine to prevent HIV infection. J Antimicrob Chemother 66: 240-250. doi:10.1093/jac/dkq447. PubMed: 21118913.
11. Robbins BL, Srinivas RV, Kim C, Bischofberger N, Fridland A, (1998) Anti-human immunodeficiency virus activity and cellular metabolism of a potential prodrug of the acyclic nucleoside phosphonate 9-R-(2-phosphonomethoxypropyl)adenine (PMPA), Bis(isopropyloxymethylcarbonyl)PMPA. Antimicrob Agents Chemother 42: 612-617. PubMed: 9517941.
12. Bianchi V, Pontis E, Reichard P, (1986) Interrelations between substrate cycles and de novo synthesis of pyrimidine deoxyribonucleoside triphosphates in 3T6 cells. Proc Natl Acad Sci U S A 83: 986-990. doi:10.1073/pnas.83.4.986. PubMed: 3456577.
13. Hunsucker SA, Mitchell BS, Spychala J, (2005) The 5'-nucleotidases as regulators of nucleotide and drug metabolism. Pharmacol Ther 107: 1-30. doi:10.1016/j.pharmthera.2005.01.003. PubMed: 15963349.
14. Zídek Z, Franková D, Holý A, (2001) Activation by 9-(R)-[2-(phosphonomethoxy)propyl]adenine of chemokine (RANTES, macrophage inflammatory protein 1alpha) and cytokine (tumor necrosis factor alpha, interleukin-10 [IL-10], IL-1beta) production. Antimicrob Agents Chemother 45: 3381-3386. doi:10.1128/AAC.45.12.3381-3386.2001. PubMed: 11709312.
15. Zídek Z, Kmonícková E, Holý A, (2007) Secretion of antiretroviral chemokines by human cells cultured with acyclic nucleoside phosphonates. Eur J Pharmacol 574: 77-84. doi:10.1016/j.ejphar.2007.07.024. PubMed: 17716649.
16. Melchjorsen J, Risør MW, Søgaard OS, O'Loughlin KL, Chow S, et al. (2011) Tenofovir selectively regulates production of inflammatory cytokines and shifts the IL-12/IL-10 balance in human primary cells. J Acquir Immune Defic Syndr 57: 265-275. doi:10.1097/QAI.0b013e3182185276. PubMed: 21471820.
17. Rodríguez-García M, Porichis F, de Jong OG, Levi K, Diefenbach TJ, et al. (2011) Expression of PD-L1 and PD-L2 on human macrophages is up-regulated by HIV-1 and differentially modulated by IL-10. J Leukoc Biol 89: 507-515. doi:10.1189/jlb.0610327. PubMed: 21097698.
18. Rodríguez-García M, Climent N, Oliva H, Casanova V, Franco R, et al. (2010) Increased alpha-defensins 1-3 production by dendritic cells in HIV-infected individuals is associated with slower disease progression. PLOS ONE 5: e9436. doi:10.1371/journal.pone.0009436. PubMed: 20195543.
19. Escribese MM, Rodríguez-García M, Sperling R, Engel SM, Gallart T, et al. (2011) Alpha-defensins 1-3 release by dendritic cells is reduced by estrogen. Reprod Biol Endocrinol 9: 118. doi:10.1186/1477-7827-9-118. PubMed: 21861873.
20. Rodriguez-Garcia M, Biswas N, Patel MV, Barr FD, Crist SG, et al. (2013) Estradiol Reduces Susceptibility of CD4(+) T Cells and Macrophages to HIV-Infection. PLOS ONE 8: e62069. doi:10.1371/journal.pone.0062069. PubMed: 23614015.
21. Lahm HW, Stein S, (1985) Characterization of recombinant human interleukin-2 with micromethods. J Chromatogr 326: 357-361. doi:10.1016/S0021-9673(01)87461-6. PubMed: 3875623.
22. Godfrey TE, Kim SH, Chavira M, Ruff DW, Warren RS, et al. (2000) Quantitative mRNA expression analysis from formalin-fixed, paraffin-embedded tissues using 5' nuclease quantitative reverse transcription-polymerase chain reaction. J Mol Diagn 2: 84-91. doi:10.1016/S1525-1578(10)60621-6. PubMed: 11272893.
23. Ghosh M, Shen Z, Fahey JV, Cu-Uvin S, Mayer K, et al. (2010) Trappin-2/Elafin: a novel innate anti-human immunodeficiency virus-1 molecule of the human female reproductive tract. Immunology 129: 207-219. doi:10.1111/j.1365-2567.2009.03165.x. PubMed: 19824918.
24. Mane VP, Heuer MA, Hillyer P, Navarro MB, Rabin RL, (2008) Systematic method for determining an ideal housekeeping gene for real-time PCR analysis. J Biomol Tech 19: 342-347.
25. Shen Z, Fahey JV, Bodwell JE, Rodriguez-Garcia M, Rossoll RM, et al. (2013) Estradiol regulation of nucleotidases in female reproductive tract epithelial cells and fibroblasts. PLOS ONE 8: e69854. doi:10.1371/journal.pone.0069854. PubMed: 23936114.
26. Krishna S, Andersson AM, Semsey S, Sneppen K, (2006) Structure and function of negative feedback loops at the interface of genetic and metabolic networks. Nucleic Acids Res 34: 2455-2462. doi:10.1093/nar/gkl140. PubMed: 16684993.
27. Christensen LD, (1996) No correlation between CD73 expression and ecto-5'-nucleotidase activity on blood mononuclear cells in vitro. Evidence of CD73 (ecto-5'-nucleotidase) on blood mononuclear cells with distinct antigenic properties. APMIS 104: 126-134. doi:10.1111/j.1699-0463.1996.tb00697.x. PubMed: 8619914.
28. Rampazzo C, Kost-Alimova M, Ruzzenente B, Dumanski JP, Bianchi V, (2002) Mouse cytosolic and mitochondrial deoxyribonucleotidases: cDNA cloning of the mitochondrial enzyme, gene structures, chromosomal mapping and comparison with the human orthologs. Gene 294: 109-117. doi:10.1016/S0378-1119(02)00651-0. PubMed: 12234672.
29. Lewis W, Dalakas MC, (1995) Mitochondrial toxicity of antiviral drugs. Nat Med 1: 417-422. doi:10.1038/nm0595-417. PubMed: 7585087.
30. Ghosh M, Shen Z, Schaefer TM, Fahey JV, Gupta P, et al. (2009) CCL20/MIP3alpha is a novel anti-HIV-1 molecule of the human female reproductive tract. Am J Reprod Immunol 62: 60-71. doi:10.1111/j.1600-0897.2009.00713.x. PubMed: 19527233.
31. Lafferty MK, Sun L, DeMasi L, Lu W, Garzino-Demo A, (2010) CCR6 ligands inhibit HIV by inducing APOBEC3G. Blood 115: 1564-1571. doi:10.1182/blood-2009-06-226423. PubMed: 20023216.
32. Sheehy AM, Gaddis NC, Choi JD, Malim MH, (2002) Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 418: 646-650. doi:10.1038/nature00939. PubMed: 12167863.
33. Schutyser E, Struyf S, Van Damme J, (2003) The CC chemokine CCL20 and its receptor CCR6. Cytokine Growth Factor Rev 14: 409-426. doi:10.1016/S1359-6101(03)00049-2. PubMed: 12948524.
34. Kwon JH, Keates S, Bassani L, Mayer LF, Keates AC, (2002) Colonic epithelial cells are a major site of macrophage inflammatory protein 3alpha (MIP-3alpha) production in normal colon and inflammatory bowel disease. Gut 51: 818-826. doi:10.1136/gut.51.6.818. PubMed: 12427784.
35. Li Q, Estes JD, Schlievert PM, Duan L, Brosnahan AJ, et al. (2009) Glycerol monolaurate prevents mucosal SIV transmission. Nature 458: 1034-1038. doi:10.1038/nature07831. PubMed: 19262509.
36. Harada A, Sekido N, Akahoshi T, Wada T, Mukaida N, et al. (1994) Essential involvement of interleukin-8 (IL-8) in acute inflammation. J Leukoc Biol 56: 559-564. PubMed: 7964163.
37. Lane BR, Lore K, Bock PJ, Andersson J, Coffey MJ, et al. (2001) Interleukin-8 stimulates human immunodeficiency virus type 1 replication and is a potential new target for antiretroviral therapy. J Virol 75: 8195-8202. doi:10.1128/JVI.75.17.8195-8202.2001. PubMed: 11483765.
38. Narimatsu R, Wolday D, Patterson BK, (2005) IL-8 increases transmission of HIV type 1 in cervical explant tissue. AIDS Res Hum Retrovir 21: 228-233. doi:10.1089/aid.2005.21.228. PubMed: 15795529.
39. Savic V, Stefanovic V, Ardaillou N, Ardaillou R, (1990) Induction of ecto-5'-nucleotidase of rat cultured mesangial cells by interleukin-1 beta and tumour necrosis factor-alpha. Immunology 70: 321-326. PubMed: 2165999.
40. Armstrong MA, Shah S, Hawkins SA, Bell AL, Roberts SD, (1988) Reduction of monocyte 5'nucleotidase activity by gamma-interferon in multiple sclerosis and autoimmune diseases. Ann Neurol 24: 12-16. doi:10.1002/ana.410240104. PubMed: 2843076.
41. Christensen LD, Andersen V, Nygaard P, Bendtzen K, (1992) Effects of immunomodulators on ecto-5'-nucleotidase activity on blood mononuclear cells in vitro. Scand J Immunol 35: 407-413. doi:10.1111/j.1365-3083.1992.tb02875.x. PubMed: 1557611.
42. Anderson PL, Glidden DV, Liu A, Buchbinder S, Lama JR, et al. (2012) Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men. Sci Transl Med 4: 151ra125. PubMed: 22972843.
43. Rodriguez-Garcia M, Patel MV, Wira CR, (2013) Innate and adaptive anti-HIV immune responses in the female reproductive tract. J Reprod Immunol 97: 74-84. doi:10.1016/j.jri.2012.10.010. PubMed: 23432874.
44. Mesquita PM, Rastogi R, Segarra TJ, Teller RS, Torres NM, et al. (2012) Intravaginal ring delivery of tenofovir disoproxil fumarate for prevention of HIV and herpes simplex virus infection. J Antimicrob Chemother 67: 1730-1738. doi:10.1093/jac/dks097. PubMed: 22467632.
45. Dobard C, Sharma S, Martin A, Pau CP, Holder A, et al. (2012) Durable protection from vaginal simian-human immunodeficiency virus infection in macaques by tenofovir gel and its relationship to drug levels in tissue. J Virol 86: 718-725. doi:10.1128/JVI.05842-11. PubMed: 22072766.